Müthing J, Cacić M
Institute of Cell Culture Technology, University of Bielefeld, Germany.
Glycoconj J. 1997 Jan;14(1):19-28. doi: 10.1023/a:1018552729572.
In this study the comparative TLC immunostaining investigation of neutral GSLs and gangliosides from human skeletal and heart muscle is described. A panel of specific polyclonal and monoclonal antibodies as well as the GM1-specific choleragenoid were used for the overlay assays, combined with preceding neuraminidase treatment of gangliosides on TLC plates. This approach proved homologies but also quantitative and qualitative differences in the expression of ganglio-, globo- and neolacto-series neutral GSLs and gangliosides in these two types of striated muscle tissue within the same species. The main neutral GSL in skeletal muscle was LacCer, followed by GbOse3Cer, GbOse4Cer, nLcOse4Cer and monohexosylceramide, whereas in heart muscle GbOse3Cer and GbOse4Cer were the predominant neutral GSLs beside small quantities of LacCer, nLcOse4Cer and monohexosylceramide. No ganglio-series neutral GSLs and no Forssman GSL were found in either muscle tissue. GM3(Neu5Ac) was the major ganglioside, comprising almost 70% in skeletal and about 50% in cardiac muscle total gangliosides. GM2 was found in skeletal muscle only, while GD3 and GM1b-type gangliosides (GM1b and GD1 alpha) were undetectable in both tissues. GM1a-core gangliosides (GM1, GD1a, GD1b and GT1b) showed somewhat quantitative differences in each muscle; lactosamine-containing IV3Neu5Ac-nLcOse4Cer was detected in both specimens. Neutral GSLs were identified in TLC runs corresponding to e.g. 0.1 g muscle wet weight (GbOse3Cer, GbOse4Cer), and gangliosides GM3 and GM2 were elucidated in runs which corresponded to 0.2 g muscle tissue. Only 0.02 g and 0.004 g wet weight aliquots were necessary for unequivocal identification of neolacto-type and GM1-core gangliosides, respectively. Muscle is known for the lowest GSL concentration from all vertebrate tissues studied so far. Using the overlay technique, reliable GSL composition could be revealed, even from small muscle probes on a sub-orcinol and sub-resorcinol detection level.
本研究描述了对人骨骼肌和心肌中中性糖鞘脂(GSLs)和神经节苷脂的比较薄层层析免疫染色研究。一组特异性多克隆和单克隆抗体以及GM1特异性霍乱类毒素用于覆盖分析,并结合在薄层层析板上对神经节苷脂进行预先的神经氨酸酶处理。该方法证明了同一物种的这两种类型横纹肌组织中神经节、球和新乳糖系列中性GSLs和神经节苷脂在表达上的同源性,以及数量和质量上的差异。骨骼肌中的主要中性GSL是乳糖神经酰胺(LacCer),其次是GbOse3Cer、GbOse4Cer、nLcOse4Cer和单己糖神经酰胺,而在心肌中,GbOse3Cer和GbOse4Cer是主要的中性GSL,此外还有少量的LacCer、nLcOse4Cer和单己糖神经酰胺。在两种肌肉组织中均未发现神经节系列中性GSLs和福斯曼GSL。GM3(Neu5Ac)是主要的神经节苷脂,在骨骼肌总神经节苷脂中占近70%,在心肌中约占50%。GM2仅在骨骼肌中发现,而GD3和GM1b型神经节苷脂(GM1b和GD1α)在两种组织中均未检测到。GM1a核心神经节苷脂(GM1、GD1a、GD1b和GT1b)在每种肌肉中显示出一定的数量差异;在两个标本中均检测到含乳糖胺的IV3Neu5Ac - nLcOse4Cer。在对应于例如0.1 g肌肉湿重的薄层层析运行中鉴定出中性GSLs(GbOse3Cer、GbOse4Cer),在对应于0.2 g肌肉组织的运行中阐明了神经节苷脂GM3和GM2。分别仅需0.02 g和0.004 g湿重的等分试样即可明确鉴定新乳糖型和GM1核心神经节苷脂。到目前为止,在所有研究的脊椎动物组织中,肌肉的GSL浓度最低。使用覆盖技术,即使是在低于苔黑酚和间苯二酚检测水平的小肌肉样本中,也能揭示可靠的GSL组成。